Before You Board

When people think about cancer treatment abroad, they often picture hospitals, flights, and hotels. In reality, the process starts much earlier: with a careful review of the medical file you already have. Not every advanced treatment fits every patient. Options such as CAR-T, proton therapy, heavy ion therapy, BNCT, iPSC-based approaches, or cancer vaccines are considered according to cancer type, stage, prior treatments, overall condition, and pathology findings. The first real question is simple: “Could I actually be a candidate for this?” That answer should come from a specialist team, not from advertising.

The first step usually includes collecting pathology reports, surgery notes, PET/CT or MRI scans, medication history, molecular or genetic test results if available, and recent blood work. Think of it like a puzzle: if one key piece is missing, the whole picture may be misread. Sometimes a translated report is not enough; pathology slides may need a second review, or additional molecular testing may be required. This matters even more for cellular therapies, where target suitability, prior treatment response, and infection risk must be checked carefully. This is not a “we’ll figure it out after arrival” stage; good preparation saves time and prevents false starts.

The next key issue is understanding the regulatory status of the planned treatment. Some therapies may be approved for specific cancers, some are offered within clinical trials, and some may be delivered as private clinical applications. That difference matters because it can affect eligibility, required tests, waiting time, and follow-up. For example, in BNCT, suitability depends not only on where the tumor is located, but also on technical factors such as boron distribution and dose planning. Supportive approaches such as exosome-based applications should also be discussed honestly as supportive care, not as stand-alone anti-tumor treatment.

One of the most reasonable questions families ask is: “What will happen once we get there?” In many cases, the path includes remote pre-assessment, specialist review, requests for additional tests if needed, a candidacy decision, travel planning, and an in-person evaluation. Some treatments are not one-day procedures; they may require preparation, hospitalization, observation, and follow-up after returning home. Risks also vary from patient to patient: infection, low blood counts, fatigue, organ function issues, and the lasting effects of earlier treatments all need to be considered. The goal is not just to find a treatment, but to build the safest and most appropriate plan for the right patient at the right time.

If you are considering treatment abroad, start with your documents. You can upload your reports to the Patient Panel on our website for a free preliminary review. Please remember that all treatment decisions are made by licensed physicians and the relevant specialist boards.